John Maraganore
About John Maraganore
John Maraganore: Board Chair
John Maraganore serves as the Board Chair for several organizations and companies. Notably, he is the Chairman and Co-founder of Orbital Therapeutics. He also serves on the Board of Directors of various publicly traded companies such as Agios Pharmaceuticals, Beam Therapeutics, Kymera Therapeutics, ProKidney Corp., and Takeda Pharmaceuticals. In addition, Maraganore participates in the governance of several private companies including Aerium, Hemab, Aera, and Versanis.
Career and Leadership at Alnylam Pharmaceuticals
John Maraganore was the founding CEO and a Director of Alnylam Pharmaceuticals from 2002 to 2021. During his tenure, he spearheaded the company's growth from early platform research on RNA interference through to the global approval and commercialization of the first four RNAi therapeutic medicines. His leadership in value creation helped Alnylam achieve a market capitalization exceeding $25 billion and facilitated the formation of over 20 strategic alliances with major pharmaceutical companies. Today, he continues to serve on Alnylam’s Scientific Advisory Board.
John Maraganore's Role at Millennium Pharmaceuticals and Biogen
John Maraganore has held strategic roles at prominent biotech firms before his tenure at Alnylam Pharmaceuticals. At Millennium Pharmaceuticals, Inc., he was responsible for managing product franchises across oncology, cardiovascular, inflammatory, and metabolic diseases. Prior to that, he served in various scientific and business capacities at Biogen, Inc., where he notably invented and led the discovery and development of ANGIOMAX® (bivalirudin) for injection.
Education and Expertise: John Maraganore
John Maraganore holds an M.S. and a Ph.D. in biochemistry and molecular biology from the University of Chicago. His advanced educational background has underpinned his successful career in the biotechnology sector, allowing him to contribute significantly to scientific research and commercial drug development.
John Maraganore's Current Positions and Advisory Roles
Currently, John Maraganore is a Venture Partner at ARCH Venture Partners and acts as a Venture Advisor at Atlas Ventures. He also holds the position of Executive Partner at RTW Investments and serves as a Senior Advisor for Blackstone Life Sciences. Additionally, Maraganore provides his expertise on several boards and advisory councils, including the Biotechnology Innovation Organization (BIO), where he was Chair from 2017 to 2019, and continues to serve as Chair Emeritus. He is also involved with the Termeer Foundation, n-Lorem Foundation Advisory Council, and Ariadne Labs, among others.